About olympus corp. - OLYMY
Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Endoscope Business and Therapeutic Equipment Business. The Endoscope Business segment develops and sells medical endoscopes and imaging systems for minimally invasive diagnostics. The Therapeutic Equipment Business segment provides medical devices and systems used in surgical and therapeutic procedures across various specialties. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.
OLYMY At a Glance
Olympus Corp.
2951 Ishikawa-cho
Hachioji, Tokyo 192-8507
| Phone | 81-42-642-2111 | Revenue | 6.71B | |
| Industry | Medical Specialties | Net Income | 452.39M | |
| Sector | Health Technology | 2026 Sales Growth | 2.52% | |
| Fiscal Year-end | 03 / 2027 | Employees | N/A | |
| View SEC Filings |
OLYMY Valuation
| P/E Current | 28.113 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 22.993 |
| Price to Sales Ratio | 1.554 |
| Price to Book Ratio | 2.018 |
| Price to Cash Flow Ratio | 15.61 |
| Enterprise Value to EBITDA | 7.559 |
| Enterprise Value to Sales | 1.602 |
| Total Debt to Enterprise Value | 0.14 |
OLYMY Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | N/A |
| Receivables Turnover | 4.266 |
| Total Asset Turnover | 0.697 |
OLYMY Liquidity
| Current Ratio | 1.617 |
| Quick Ratio | 1.143 |
| Cash Ratio | 0.43 |
OLYMY Profitability
| Gross Margin | 64.718 |
| Operating Margin | 14.546 |
| Pretax Margin | 9.666 |
| Net Margin | 6.745 |
| Return on Assets | 4.702 |
| Return on Equity | 8.931 |
| Return on Total Capital | 6.844 |
| Return on Invested Capital | 7.323 |
OLYMY Capital Structure
| Total Debt to Total Equity | 29.503 |
| Total Debt to Total Capital | 22.782 |
| Total Debt to Total Assets | 15.586 |
| Long-Term Debt to Equity | 19.667 |
| Long-Term Debt to Total Capital | 15.186 |